To read the full 2022 i&E OKBIO edition, click here.Read more
News
Thank you for reading this column for nearly a decade By Scott Meacham This is my final column for The Oklahoman. As CEO of i2E, I have had the wonderful opportunity since January 2013 to write this weekly column for the readers of this newspaper. That stacks up to more than 460 columns on all aspects ofRead more
By Scott Meacham Entrepreneurs are the rising tide that lifts all our boats. It is the season to count our blessings and the people and things for which we are most thankful. In some industries, the last few weeks of the year provide time to take a breath and take a break. That is notRead more
By Scott Meacham We have to make sure that Oklahoma innovators know that there are resources and mentoring available to them here. Twenty-five years ago, Oklahoma did not have a continuum of venture capital serving concept to growth stage companies. Now we do — thanks to assistance from the state acting through OCAST — fromRead more
By Scott Meacham Oklahoma companies change people’s health and their lives. In a recent conversation, an associate described Dr. Steve Prescott’s impact on Oklahoma’s bioscience economy as “standing on the shoulders of a giant.” Indeed, as the leader of the Oklahoma Medical Research Foundation (OMRF), Steve was a visionary who got things done. However, SteveRead more
Back to Newsletter By Scott Meacham Oklahoma lost a great one recently with the passing of Steve Prescott after a lengthy battle with cancer. About everyone who has ever picked up the newspaper or been active in Oklahoma City business and social circles knows Steve as the long-time leader of the Oklahoma Medical Research FoundationRead more
By Scott Meacham In entrepreneurship and venture investing, “what if” is the cornerstone of our industry. Entrepreneurship is built on promise and possibility—the willingness to imagine the unimaginable and take the risks to make it real. We all engage in the “what if” game. Oklahoma bought into “what if” in the late 1980s with theRead more
By Scott Meacham “When the student is ready, the teacher will appear.” We don’t really know who said this first—maybe Buddha or a Zen master — but the idea is endlessly powerful. When we open our minds and our eyes, we can learn so much from wherever we find ourselves. From wearing so many differentRead more
Contact: April Stuart (405) 319-8260 astuart@phfokc.com FOR IMMEDIATE RELEASE OKLAHOMA CITY, July 20, 2020: The Presbyterian Health Foundation has awarded nearly $4.6 million in biomedical research grants to the University of Oklahoma Health Sciences Center (OUHSC) and the Oklahoma Medical Research Foundation (OMRF). “We remain steadfastly committed to funding cutting-edge biomedical research on the OklahomaRead more
Read the entire story at the Journal Record (subscription required)Read more
PR Newswire February 11, 2020 Pill to restore natural hearing moves one step closer to market OKLAHOMA CITY, Feb. 11, 2020 /PRNewswire/ — Hough Ear Institute (HEI), a nonprofit based in Oklahoma City, is proud to announce that its pharmaceutical partner, Auditus LLC (Auditus), a wholly owned subsidiary of Otologic Pharmaceutics Inc. (OPI), hasRead more
By Scott Meacham There is very big news this month for individuals and families affected by sickle cell disease (SCD). The U.S. Food and Drug Administration (FDA) has approved the first targeted treatment to reduce the frequency of pain crises in individuals living with SCD. This new drug — Adakveo® from Novartis — decreases theRead more
By Stephen Prescott, M.D. When Novartis announced earlier this month that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have. That drug, known as Adakveo, is as Oklahoman as redbuds and scissor-tailed flycatchers. Indeed, but for workRead more
By Scott Meacham Copyright © 2019, The Oklahoman Of the more than 120 types of brain and central nervous system tumors, Glioblastoma (also called GBM) is the most aggressive — a deadly brain cancer with no cure. Glioblastomas often appear with no warning or prior symptoms. These Type IV tumors tend to produce their ownRead more
By Kevan Goff-Parker Copyright ©2019, The Oklahoman PHILADELPHIA — More than 40 Oklahoma bioscience and industry experts from a wide array of fields are busy telling global industry leaders about the state’s successes in the bioscience sector during the BIO International Conference held Tuesday through Thursday at the Pennsylvania Convention Center in Philadelphia. Manu Nair,Read more
By Scott Meacham Copyright © 2019, The Tulsa World/BH Media Group The Oklahoma Medical Research Foundation is one of the finest biomedical research institutions in the world. I2E is honored to be a commercialization partner with this organization of 400-plus scientists who evince such a passion and singular focus on understanding and curing human disease.Read more
By Jim Stafford Copyright © 2018, The Oklahoman As keynote speaker at last week’s Oklahoma Center for Science and Technology (OCAST) Health Research Conference, James A. Rogers III, with Mayo Clinic, delivered a sobering forecast for scientists seeking to commercialize discoveries made in their laboratories. “It’s a bit of a roller coaster to be involvedRead more
By Scott Meacham Copyright © (2017), The Oklahoma Publishing Co. The holiday season is a time of hope, optimism, and belief in all possibilities and, for some, even the belief in impossibilities. In our line of business at i2E, we regularly work shoulder to shoulder with Oklahoma-based startups and entrepreneurs who battle the seemingly impossibleRead more
By CAROLINA HENRIQUES Lupas News Today Progentec Diagnostics is closer to marketing a new set of tools for predicting lupus flares after obtaining $1.25 million in financing. The Oklahoma Medical Research Foundation created the technology the company is using. Progentec is collaborating with Dr. Judith James, a lupus researcher who developed the technology, to refineRead more
By Paula Burkes Copyright © 2017, The Oklahoma Publishing Co. Scientists don’t yet know why some 1.5 million Americans have lupus, an autoimmune disease in which the body attacks its own healthy tissues. Symptoms surface mostly in women ages 16 to 34 and vary from rashes and joint pain to deadly organ failure. Physician-scientist JudithRead more
